Literature DB >> 11784295

Interferon-alpha inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes.

Sven Erickson1, Sampsa Matikainen, Lena Thyrell, Olle Sangfelt, Ilkka Julkunen, Stefan Einhorn, Dan Grandér.   

Abstract

It has previously been shown that IFN-alpha is a potent inhibitor of IL-2 induced proliferation in primary T-lymphocytes, by selectively abrogating the downstream effects of IL-2 on the core cell cycle machinery regulating the G1/S transition. Theoretically this could be mediated through cross-talk between the signalling cascades activated by these cytokines, as several signalling components are known to be shared. IL-2 activates multiple signalling pathways that are important for T-cell proliferation and differentiation. In the present study, the effects of IFN-alpha on IL-2 signal transduction was investigated. The IFN-alpha induced inhibition of IL-2 induced proliferation in activated T-lymphocytes, was associated with a suppressed Jak3 protein expression as well as an inhibited prolonged Stat5 DNA binding, and a partially reduced expression of the Stat5 inducible gene IL-2R alpha. Our results provide a possible molecular link between the prominent antiproliferative effects of IFN-alpha on IL-2 induced T-cell proliferation and the signal transduction pathways emerging from the IL-2 receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11784295     DOI: 10.1046/j.0014-2956.2002.02626.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  7 in total

1.  Epstein-Barr virus latent membrane protein LMP-2A is sufficient for transactivation of the human endogenous retrovirus HERV-K18 superantigen.

Authors:  Natalie Sutkowski; Gang Chen; German Calderon; Brigitte T Huber
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  Interferon-α inhibits CD4 T cell responses to interleukin-7 and interleukin-2 and selectively interferes with Akt signaling.

Authors:  Thao P Nguyen; Doug A Bazdar; Joseph C Mudd; Michael M Lederman; Clifford V Harding; Gareth A Hardy; Scott F Sieg
Journal:  J Leukoc Biol       Date:  2015-03-17       Impact factor: 4.962

3.  Human metapneumovirus keeps dendritic cells from priming antigen-specific naive T cells.

Authors:  Pablo F Céspedes; Pablo A Gonzalez; Alexis M Kalergis
Journal:  Immunology       Date:  2013-07       Impact factor: 7.397

4.  Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response.

Authors:  Shirin Munir; Philippa Hillyer; Cyril Le Nouën; Ursula J Buchholz; Ronald L Rabin; Peter L Collins; Alexander Bukreyev
Journal:  PLoS Pathog       Date:  2011-04-21       Impact factor: 6.823

5.  Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin.

Authors:  Tae-Hee Lee; Kee-Ook Lee; Yong-Seok Kim; Sun-Moon Kim; Kyu-Chan Huh; Young-Woo Choi; Young-Woo Kang
Journal:  Korean J Intern Med       Date:  2014-04-29       Impact factor: 2.884

6.  Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis.

Authors:  Tobias Kind; Eunho Cho; Taeeun D Park; Nan Deng; Zhenqiu Liu; Tack Lee; Oliver Fiehn; Jayoung Kim
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

7.  The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling.

Authors:  Donald T Gracias; Erietta Stelekati; Jennifer L Hope; Alina C Boesteanu; Travis A Doering; Jillian Norton; Yvonne M Mueller; Joseph A Fraietta; E John Wherry; Martin Turner; Peter D Katsikis
Journal:  Nat Immunol       Date:  2013-04-21       Impact factor: 25.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.